Peer-influenced content. Sources you trust. No registration required. This is HCN.
GoodRx for Healthcare Professionals
Eleven commonly prescribed medication classes have been associated with new or worsening depression symptoms, with risk varying by dose, duration, and patient population.
Family Medicine/General Practice May 8th 2026
Conexiant
Smartwatch-derived nighttime scratching metrics correlated moderately with disease severity and short-term treatment response in a small pediatric atopic dermatitis cohort.
Dermatology May 7th 2026
Psych Congress Network
Algorithm-guided treatment was associated with improved remission rates in 5 of 7 randomized trials of major depressive disorder, though heterogeneity in protocols and outcome measures limited direct comparability.
Psychiatry April 29th 2026
Psychiatry Advisor
“Additional research is needed to determine whether the modest elevations in suicidal behavior observed during treatment are due to true medication effects or to persistence in the distress that prompted treatment initiation.” — Study authors, Biological Psychiatry Global Open Science
Neurology April 1st 2026
EP Lab Digest
There needs to be increased awareness among primary care doctors and general cardiologists that patients with persistent symptomatic AF are sometimes better served by promptly scheduling a cardioversion while waiting for an appointment with an electrophysiologist.
Cardiology March 25th 2026
Physician’s Weekly
Mean adjusted adult BMI was significantly higher among individuals with childhood ADHD compared with controls, with the highest BMI observed in those treated with MPH for ≥365 days.
Family Medicine/General Practice January 28th 2026